Cargando…
Response to: “Utility of endogenous 4β-hydroxycholesterol as a biomarker to assess cytochrome P 450 3A (CYP3A) activity: not quite ready for prime time”
Autores principales: | Kvitne, Kine Eide, Hole, Kristine, Molden, Espen, Robertsen, Ida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546967/ https://www.ncbi.nlm.nih.gov/pubmed/36098754 http://dx.doi.org/10.1007/s00228-022-03387-y |
Ejemplares similares
-
Utility of endogenous 4β-hydroxycholesterol as a biomarker to assess cytochrome P 450 3A (CYP3A) activity: not quite ready for prime time
por: Tung, Norint P., et al.
Publicado: (2022) -
Correlations between 4β-hydroxycholesterol and hepatic and intestinal CYP3A4: protein expression, microsomal ex vivo activity, and in vivo activity in patients with a wide body weight range
por: Eide Kvitne, Kine, et al.
Publicado: (2022) -
Impact of type 2 diabetes on in vivo activities and protein expressions of cytochrome P450 in patients with obesity
por: Kvitne, Kine Eide, et al.
Publicado: (2022) -
Elevated 4β‐hydroxycholesterol/cholesterol ratio in anorexia nervosa patients
por: Hole, Kristine, et al.
Publicado: (2018) -
Short‐ and long‐term effects of body weight loss following calorie restriction and gastric bypass on CYP3A‐activity – a non‐randomized three‐armed controlled trial
por: Kvitne, Kine Eide, et al.
Publicado: (2021)